Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-04-06

Clinical Trial Update: Memantine for Agitation in Dementia [Phase 4]

View source ↗

Summary

Clinical trial update for memantine in dementia (Phase 4) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Memantine (memantine)

Snippet

Sponsor: East Kent Hospitals University NHS Foundation Trust | Conditions: DEMENTIA | Phase 4 | Status: COMPLETED